[1]
O. V. Golianovskyi, O. O. Andrienko, O. V. Furman, and P. Boyle, “Prospective of low dose naltrexone use in treatment of autoimmune pathology and endometriosis”, RE, no. 55, pp. 53–57, Nov. 2020.